Cheshire, United Kingdom

Mark Andrew Graham

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Andrew Graham. Retrieved from https://idiyas.com/inventor/mark-andrew-graham-c8dw68l8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Macclesfield, GB (2011)
  • Cheshire, GB (2018 - 2019)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mark Andrew Graham: Innovator in Chemical Compounds

Introduction

Mark Andrew Graham is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of chemical compounds, particularly in the development of pharmaceutical compositions for cancer treatment. With a total of three patents to his name, Graham's work is recognized for its potential impact on medical science.

Latest Patents

Graham's latest patents focus on chemical compounds that are crucial in the fight against cancer. The present disclosures concern compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R, R, and R have specific meanings defined in the description. These patents also detail processes for the preparation of these compounds, as well as pharmaceutical compositions containing them and their use in cancer treatment.

Career Highlights

Mark Andrew Graham is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to innovative solutions in healthcare, particularly in oncology.

Collaborations

Graham has collaborated with notable colleagues, including Clifford David Jones and Richard Andrew Ward. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical innovations.

Conclusion

Mark Andrew Graham's contributions to the field of chemical compounds and his dedication to cancer treatment exemplify the spirit of innovation in the pharmaceutical industry. His work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…